Indivior Pharmaceuticals, Inc. - Common Stock (INDV)

33.89
-0.55 (-1.60%)
NASDAQ · Last Trade: Feb 22nd, 5:27 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Vistance Networks Stock Up 250%. Here's Why a $40 Million Position Signals a Post-Divestiture Betfool.com
Vistance Networks delivers connectivity and network solutions for telecom, data centers, and enterprise clients worldwide.
Via The Motley Fool · February 22, 2026
Array Stock Down 25%, But This $17.3 Million Buy Signals Confidence Amid Big Revenue Growthfool.com
Array Digital Infrastructure delivers wireless services and device sales to consumers, businesses, and government clients nationwide.
Via The Motley Fool · February 22, 2026
Enviri Stock Up 120% as $43 Million Buy Makes It a Top Holding in This Portfoliofool.com
Enviri delivers environmental and specialty waste solutions for industrial clients through long-term contracts and value-added products.
Via The Motley Fool · February 22, 2026
INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) Presents a High-Growth Momentum and Technical Setup Casechartmill.com
Via Chartmill · February 20, 2026
INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) Presents a High-Growth Momentum Breakout Setupchartmill.com
Via Chartmill · January 27, 2026
Earnings Scheduled For October 30, 2025benzinga.com
Via Benzinga · October 30, 2025
Earnings Scheduled For July 31, 2025benzinga.com
Via Benzinga · July 31, 2025
Integer Stock Down 38%, but One Fund Just Bet $40 Million on a Turnaroundfool.com
Integer Holdings supplies medical device components and finished products to major OEMs in cardiac, neuro, and surgical markets.
Via The Motley Fool · February 22, 2026
Mangrove Partners Loads Up Flywire With 2.9 Million Sharesfool.com
The new holding places Flywire outside the fund’s top five positions.
Via The Motley Fool · December 30, 2025
INDIVIOR PLC (NASDAQ:INDV) Presents a High-Growth Momentum and Technical Breakout Setupchartmill.com
INDIVIOR stock combines high-growth earnings momentum with a strong technical uptrend and a current bull flag setup for a potential breakout.
Via Chartmill · December 29, 2025
This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Tablefool.com
When a biotech rallies nearly 200% and still gets trimmed, the real story likely isn’t about fear or a loss of conviction.
Via The Motley Fool · December 28, 2025
Earnings Scheduled For April 24, 2025benzinga.com
Via Benzinga · April 24, 2025
A Look at Indivior's Upcoming Earnings Reportbenzinga.com
Via Benzinga · April 23, 2025
Bardin Hill Dumps 349,000 Shares of Frontier Communicaitons Stock Worth $12.7 Millionfool.com
The position previously accounted for 7.48% of fund AUM as of the prior quarter.
Via The Motley Fool · December 18, 2025
Millrose Properties Stock Has Surged 48% Since February Debut — So Why Did One Investor Sell a $23 Million Stake?fool.com
A newly public real-estate platform is putting up numbers that look far more seasoned than its age.
Via The Motley Fool · December 7, 2025
Why One Investor Bought $67.5 Million in Array Digital Infrastructure Stockfool.com
One fund just made a bold bet on a telecom stock undergoing a big transformation
Via The Motley Fool · December 7, 2025
Why One Value Fund Has a $101 Million Bet on Indivior Stock Amid a 212% Surgefool.com
This fund just doubled down on a stock that’s suddenly delivering the earnings momentum it’s promised for years.
Via The Motley Fool · December 7, 2025
Why One Value Fund Just Bought $30 Million of a Diagnostics Stock Down 90% From Pandemic-Era Highsfool.com
A beaten-down diagnostics stock is quietly tightening margins and drawing fresh institutional conviction—here’s what that means for long-term investors.
Via The Motley Fool · December 7, 2025
The Remitly Reassessment: What Divisadero’s 95 Million Exit Tells Us About Digital Money Movementfool.com
Divisadero’s $95 million selloff sends a message about where Remitly stands in the shifting economics of global money movement. Here’s what that signal may mean for long-term investors.
Via The Motley Fool · December 3, 2025
Here's Why Indivior Stock Soared 15% Todayfool.com
This company is accelerating sales growth in its key prescription medication.
Via The Motley Fool · October 30, 2025
INDIVIOR PLC (NASDAQ:INDV) Shows Top Technical and Setup Ratings for Potential Breakoutchartmill.com
INDIVIOR (INDV) shows strong technicals with a perfect 10 rating and a 9 setup score, signaling a potential breakout above $25.20 resistance.
Via Chartmill · October 20, 2025
This Palvella Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesdaybenzinga.com
Via Benzinga · August 6, 2025
Indivior (INDV) Q2 EPS Jumps 104%fool.com
Via The Motley Fool · August 1, 2025
Roblox, Carvana, eBay, C.H. Robinson Worldwide, Huntington Ingalls Industries And Other Big Stocks Moving Higher On Thursdaybenzinga.com
Via Benzinga · July 31, 2025
Indivior (INDV) Q1 2025 Earnings Callfool.com
Via The Motley Fool · April 24, 2025